BlackRock
TNYA icon

BlackRock’s Tenaya Therapeutics TNYA Stock Holding History

BlackRock’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56M Sell
3,703,955
-244,631
-6% -$181K ﹤0.01% 4061
2025
Q4 		$2.81M Buy
3,948,586
+1,621,385
+70% +$2.21M ﹤0.01% 4021
2025
Q3 		$3.77M Sell
2,327,201
-405,599
-15% -$409K ﹤0.01% 3898
2025
Q2 		$1.67M Sell
2,732,800
-2,523,802
-48% -$1.28M ﹤0.01% 4117
2025
Q1 		$3M Sell
5,256,602
-39,874
-0.8% -$39.3K ﹤0.01% 3860
2024
Q4 		$7.57M Buy
5,296,476
+1,190,171
+29% +$2.67M ﹤0.01% 3556
2024
Q3 		$7.93M Buy
4,106,305
+32,249
+0.8% +$91K ﹤0.01% 3519
2024
Q2 		$12.6M Sell
4,074,056
-626,941
-13% -$2.59M ﹤0.01% 3247
2024
Q1 		$24.6M Buy
4,700,997
+914,173
+24% +$4.37M ﹤0.01% 2876
2023
Q4 		$12.3M Sell
3,786,824
-896,343
-19% -$1.93M ﹤0.01% 3283
2023
Q3 		$11.9M Buy
4,683,167
+1,047,019
+29% +$4.38M ﹤0.01% 3230
2023
Q2 		$21.3M Buy
3,636,148
+850,661
+31% +$4.94M ﹤0.01% 3005
2023
Q1 		$7.94M Buy
2,785,487
+524,792
+23% +$1.47M ﹤0.01% 3439
2022
Q4 		$4.54M Sell
2,260,695
-180,686
-7% -$441K ﹤0.01% 3766
2022
Q3 		$7.08M Sell
2,441,381
-21,548
-0.9% -$101K ﹤0.01% 3601
2022
Q2 		$13.9M Buy
2,462,929
+34,057
+1% +$276K ﹤0.01% 3310
2022
Q1 		$28.6M Buy
2,428,872
+555,928
+30% +$6.73M ﹤0.01% 2942
2021
Q4 		$35.5M Buy
1,872,944
+253,225
+16% +$5.52M ﹤0.01% 2908
2021
Q3 		$33.4M Buy
+1,619,719
New +$34.8M ﹤0.01% 2924

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

BlackRock's TNYA Position: Q1 2026 in Review

BlackRock reduced its Tenaya Therapeutics (TNYA) stake by 6.2% in Q1 2026, selling an estimated $181K and leaving 3,703,955 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #4061.

BlackRock first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $35.5M in Q4 2021. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • BlackRock held 3,703,955 shares of Tenaya Therapeutics worth $2.56M as of Q1 2026.
  • BlackRock sold 244,631 Tenaya Therapeutics shares in Q1 2026, an estimated $181K.
  • Tenaya Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4061 holding.
  • BlackRock first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • BlackRock's Tenaya Therapeutics position peaked at $35.5M in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.